Between £1870 and £2230
About This clinical research study
Eczema, which is also known as atopic dermatitis, is one of the most common types of skin diseases. The common feature of this inflammatory skin disease is itching. Eczema often relapses, meaning symptoms will improve for a while but then return. Currently there is no cure for the disease.
Many people with eczema improve their condition and relieve their symptoms using moisturising treatments and drugs such as steroid creams, lifestyle changes and phototherapy (treatment with light). However, for about 20% of people with moderate to severe forms of eczema these treatments are not as effective especially in the long term.
Between £1870 and £2230
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at the MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
At MAC Clinical Research we understand there is a need for new and improved treatments, and we are conducting a clinical trial to test a new topical ointment.
Up to 130 eligible participants will receive the study drug or matching placebo (a ‘dummy medication’ containing no active ingredient or drug)
Part A will run at our Manchester clinic and will consist of up to 40 patients over 4-5 cohorts.
Reimbursement: Between £1870 and £2230
Key Inclusion Criteria
Key Exclusion Criteria
Other eligibility criteria will apply. Please contact MAC for more information.
Eligible patients will receive a health screen and study participation will be in collaboration with the patient’s treating physician.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here: